ORIGINAL RESEARCH
Published on 18 Feb 2026
Serum fibroblast growth factor 21 is a novel biomarker of cachexia in chronic liver disease
doi 10.3389/fnut.2026.1730695
- 199 views
- Frontiers in Medicine
- Hepatobiliary Diseases
- Research Topics
- Bridging Molecular Drivers with New Therapies for Chronic Liver Disease Progression
Bridging Molecular Drivers with New Therapies for Chronic Liver Disease Progression
163
Total downloads
1,891
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.